Barcelos K C, Furtado D P, Ramacciato J C, Cabral A M, Haas D A
Universidade Federal do Espírito Santo, Vitória ES Furtado, Vitoria, Espírito Santo.
Anesth Prog. 2010 Fall;57(3):104-8. doi: 10.2344/0003-3006-57.3.104.
Alterations in arterial PaCO₂ can influence local anesthetic toxicity. The objective of this study was to evaluate the effect of stress-induced changes in PaCO₂ and PaO₂ on the seizure threshold of lidocaine and articaine. Lidocaine (2% with 1 : 100,000 epinephrine) or articaine (4% with 1 : 100,000 epinephrine) was administered intravenously under rest or stress conditions to 36 rats separated into 4 groups. Propranolol and prazosin were administered preoperatively to minimize cardiovascular effects of epinephrine. Mean arterial pressure (MAP), heart rate (HR), and arterial pH, PaCO₂, and PaO₂ were measured. Results showed no differences in MAP, HR, or pH. Stress significantly increased the latency period for the first tonic-clonic seizure induced by a toxic dose of both lidocaine and articaine (P < .05). Seizures were brought on more rapidly by articaine. No significant difference between toxic doses of lidocaine and articaine was noted. Stress raised the seizure threshold dose for both drugs and significantly (P < .01) increased arterial PaO₂ from 94.0 ± 1.90 mm Hg to 113.0 ± 2.20 mm Hg, and reduced PaCO₂ from 36.0 ± 0.77 mm Hg to 27.0 ± 0.98 mm Hg. In conclusion, reduction in PaCO₂ and/or increase in PaO₂ raised the seizure threshold of lidocaine and articaine. This study also confirmed that lidocaine and articaine have equipotent central nervous system toxicity.
动脉血二氧化碳分压(PaCO₂)的改变会影响局部麻醉药的毒性。本研究的目的是评估应激诱导的PaCO₂和PaO₂变化对利多卡因和阿替卡因惊厥阈值的影响。将36只大鼠分为4组,在静息或应激条件下静脉注射利多卡因(2%加1∶100,000肾上腺素)或阿替卡因(4%加1∶100,000肾上腺素)。术前给予普萘洛尔和哌唑嗪以尽量减少肾上腺素对心血管的影响。测量平均动脉压(MAP)、心率(HR)以及动脉血pH、PaCO₂和PaO₂。结果显示MAP、HR或pH无差异。应激显著延长了毒性剂量的利多卡因和阿替卡因诱发首次强直阵挛性惊厥的潜伏期(P <.05)。阿替卡因诱发惊厥的速度更快。未观察到利多卡因和阿替卡因毒性剂量之间的显著差异。应激提高了两种药物的惊厥阈值剂量,并使动脉血PaO₂从94.0±1.90 mmHg显著(P <.01)升高至113.0±2.20 mmHg,使PaCO₂从36.0±0.77 mmHg降至27.0±0.98 mmHg。总之,PaCO₂降低和/或PaO₂升高提高了利多卡因和阿替卡因的惊厥阈值。本研究还证实利多卡因和阿替卡因具有等效的中枢神经系统毒性。